Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 19109025)

1.

A brief tour of myxobacterial secondary metabolism.

Weissman KJ, Müller R.

Bioorg Med Chem. 2009 Mar 15;17(6):2121-36. doi: 10.1016/j.bmc.2008.11.025. Epub 2008 Nov 18. Review.

PMID:
19109025
2.

Non-modular polyketide synthases in myxobacteria.

Li Y, Müller R.

Phytochemistry. 2009 Oct-Nov;70(15-16):1850-7. doi: 10.1016/j.phytochem.2009.05.003. Epub 2009 Jul 6. Review.

PMID:
19586645
3.
4.

Myxobacterial secondary metabolites: bioactivities and modes-of-action.

Weissman KJ, Müller R.

Nat Prod Rep. 2010 Sep;27(9):1276-95. doi: 10.1039/c001260m. Epub 2010 Jun 3. Review. No abstract available.

PMID:
20520915
5.

Analysis of myxobacterial secondary metabolism goes molecular.

Bode HB, Müller R.

J Ind Microbiol Biotechnol. 2006 Jul;33(7):577-88. Epub 2006 Feb 21. Review.

PMID:
16491362
6.

Myxobacterial natural product assembly lines: fascinating examples of curious biochemistry.

Wenzel SC, Müller R.

Nat Prod Rep. 2007 Dec;24(6):1211-24. Epub 2007 Jun 11. Review.

PMID:
18033576
7.

Myxobacteria--'microbial factories' for the production of bioactive secondary metabolites.

Wenzel SC, Müller R.

Mol Biosyst. 2009 Jun;5(6):567-74. doi: 10.1039/b901287g. Epub 2009 Apr 23. Review.

PMID:
19462013
8.
9.

NtcA: a negative regulator of secondary metabolite biosynthesis in Sorangium cellulosum.

Rachid S, Gerth K, Müller R.

J Biotechnol. 2009 Mar 10;140(1-2):135-42. doi: 10.1016/j.jbiotec.2008.10.010. Epub 2008 Nov 12.

PMID:
19041909
10.

Biology and global distribution of myxobacteria in soils.

Dawid W.

FEMS Microbiol Rev. 2000 Oct;24(4):403-27. Review.

11.

Chapter 3. Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods.

Garcia RO, Krug D, Müller R.

Methods Enzymol. 2009;458:59-91. doi: 10.1016/S0076-6879(09)04803-4.

PMID:
19374979
12.

The biosynthetic potential of myxobacteria and their impact in drug discovery.

Wenzel SC, Müller R.

Curr Opin Drug Discov Devel. 2009 Mar;12(2):220-30. Review.

PMID:
19333867
13.

Myxobacteria isolated in Israel as potential source of new anti-infectives.

Gaspari F, Paitan Y, Mainini M, Losi D, Ron EZ, Marinelli F.

J Appl Microbiol. 2005;98(2):429-39.

PMID:
15659197
14.

A transposon-based strategy to scale up myxothiazol production in myxobacterial cell factories.

Sandmann A, Frank B, Müller R.

J Biotechnol. 2008 Jun 30;135(3):255-61. doi: 10.1016/j.jbiotec.2008.05.001. Epub 2008 May 13.

PMID:
18555551
15.

Antibiotics from myxobacteria.

Schäberle TF, Lohr F, Schmitz A, König GM.

Nat Prod Rep. 2014 Jul;31(7):953-72. doi: 10.1039/c4np00011k. Epub 2014 May 19. Review.

PMID:
24841474
16.

A unique mechanism for methyl ester formation via an amide intermediate found in myxobacteria.

Müller I, Weinig S, Steinmetz H, Kunze B, Veluthoor S, Mahmud T, Müller R.

Chembiochem. 2006 Aug;7(8):1197-205.

PMID:
16807964
17.

Phenylnannolones A-C: biosynthesis of new secondary metabolites from the myxobacterium Nannocystis exedens.

Ohlendorf B, Leyers S, Krick A, Kehraus S, Wiese M, König GM.

Chembiochem. 2008 Dec 15;9(18):2997-3003. doi: 10.1002/cbic.200800434.

PMID:
19040244
18.

Myxobacteria: natural pharmaceutical factories.

Diez J, Martinez JP, Mestres J, Sasse F, Frank R, Meyerhans A.

Microb Cell Fact. 2012 Apr 30;11:52. doi: 10.1186/1475-2859-11-52.

19.

New methods for stereochemical determination of complex polyketides: configurational assignment of novel metabolites from myxobacteria.

Menche D.

Nat Prod Rep. 2008 Oct;25(5):905-18. doi: 10.1039/b707989n. Epub 2008 Jul 18. Review.

PMID:
18820758
20.

The impact of genomics on the exploitation of the myxobacterial secondary metabolome.

Wenzel SC, Müller R.

Nat Prod Rep. 2009 Nov;26(11):1385-407. doi: 10.1039/b817073h. Epub 2009 Jul 28. Review. No abstract available.

PMID:
19844638
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk